Sinonasal outcome test validated for endoscopic Sx

Sinonasal outcome test validated for endoscopic sx

(HealthDay)—Statistical and measurement evidence validates the comparison of the 22-item Sinonasal Outcome Test (SNOT-22) responses or scale scores before and after endoscopic sinus surgery to quantify changes in symptoms and dysfunctions in patients with chronic rhinosinusitis (CRS), according to a study published online June 26 in JAMA Otolaryngology.

Adam S. DeConde, M.D., from the Oregon Health & Science University in Portland, and colleagues evaluated pre- and postoperative data from the SNOT-22 survey from a population-based sample of adults with CRS who elected surgical intervention for continuing medically refractory symptoms. Models were estimated to test structure, potential response shifts, and true change in the SNOT-22 scores.

The researchers found that, based on the 339 participants completing both evaluations, five correlated, yet distinguishable, underlying factors were revealed in analysis of SNOT-22. The largest impact of endoscopic was seen across these factors with regard to rhinologic symptoms (P < 0.001) and extranasal rhinologic symptoms (P < 0.05). A smaller, but significant effect was seen across the other three factors: ear/facial symptoms (P < 0.001), psychological dysfunction (P < 0.05), and sleep dysfunction (P < 0.001).

"Participants undergoing experience only clinically insignificant response shifts, validating assessment of change through use of presurgery and postsurgery SNOT-22 responses," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Increasing malarial drug resistance a growing threat

7 hours ago

(HealthDay)—The parasite that causes malaria is growing increasingly resistant to the drugs commonly used to fight it, according to new surveillance reports. But several new drugs are in development, and ...

User comments